Selective killing of B-cell hybridomas targeting proteinase 3, Wegener's autoantigen.
about
The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma.Engineered human angiogenin mutations in the placental ribonuclease inhibitor complex for anticancer therapy: Insights from enhanced sampling simulations.
P2860
Selective killing of B-cell hybridomas targeting proteinase 3, Wegener's autoantigen.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Selective killing of B-cell hybridomas targeting proteinase 3, Wegener's autoantigen.
@en
Selective killing of B-cell hybridomas targeting proteinase 3, Wegener's autoantigen.
@nl
type
label
Selective killing of B-cell hybridomas targeting proteinase 3, Wegener's autoantigen.
@en
Selective killing of B-cell hybridomas targeting proteinase 3, Wegener's autoantigen.
@nl
prefLabel
Selective killing of B-cell hybridomas targeting proteinase 3, Wegener's autoantigen.
@en
Selective killing of B-cell hybridomas targeting proteinase 3, Wegener's autoantigen.
@nl
P2093
P2860
P1433
P1476
Selective killing of B-cell hybridomas targeting proteinase 3, Wegener's autoantigen.
@en
P2093
Andreas Engert
Anne Krüssmann
Elena Csernok
Elke Pogge Von Strandmann
Gisela Schön
Hinrich P Hansen
Katrin S Reiners
Wolfgang L Gross
P2860
P304
P356
10.1111/J.1365-2567.2004.01875.X
P577
2004-06-01T00:00:00Z